apremilast (Otezla)

From Aaushi
Jump to navigation Jump to search
[1][2]

Indications

Contraindications

Monitor

Adverse effects

Mechanism of action

More general terms

References

  1. ↑ 1.0 1.1 FDA News Release: March 21, 2014 FDA approves Otezla to treat psoriatic arthritis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm390091.htm
  2. ↑ 2.0 2.1 2.2 2.3 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, American College of Physicians, Philadelphia 2015, 2018.
Retrieved from "https://aaushi.info/w/index.php?title=A439872&oldid=1115673"